ArticleMedicine2020

Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial.

Stefan Siebert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.